These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31609051)

  • 21. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers.
    Hohnloser SH; Klingenheben T; Li YG; Zabel M; Peetermans J; Cohen RJ
    J Cardiovasc Electrophysiol; 1998 Dec; 9(12):1258-68. PubMed ID: 9869525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragmented QRS complex predicts the arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Canpolat U; Kabakçi G; Aytemir K; Dural M; Sahiner L; Yorgun H; Sunman H; Bariş Kaya E; Tokgözoğlu L; Oto A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1260-6. PubMed ID: 23845044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of chronic kidney disease and renal replacement therapy in ventricular tachyarrhythmias and aborted cardiac arrest.
    Weidner K; Behnes M; Schupp T; Rusnak J; Reiser L; Taton G; Reichelt T; Ellguth D; Engelke N; Bollow A; El-Battrawy I; Ansari U; Hoppner J; Nienaber CA; Mashayekhi K; Weiß C; Akin M; Borggrefe M; Akin I
    Clin Res Cardiol; 2019 Jun; 108(6):669-682. PubMed ID: 30578436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory ECG-based T-wave alternans and heart rate turbulence predict high risk of arrhythmic events in patients with old myocardial infarction.
    Maeda S; Nishizaki M; Yamawake N; Ashikaga T; Shimada H; Asano M; Ihara K; Murai T; Suzuki H; Fujii H; Sakurada H; Hiraoka M; Isobe M
    Circ J; 2009 Dec; 73(12):2223-8. PubMed ID: 19838004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambulatory electrocardiographic markers predict serious cardiac events in patients with chronic kidney disease: The Japanese Noninvasive Electrocardiographic Risk Stratification of Sudden Cardiac Death in Chronic Kidney Disease (JANIES-CKD) study.
    Hashimoto K; Kinoshita T; Miwa Y; Amino M; Yoshioka K; Yodogawa K; Nakagawa M; Nakamura K; Watanabe E; Nakamura K; Watanabe T; Kasamaki Y; Ikeda T
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12923. PubMed ID: 34873791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.
    Waks JW; Hamilton C; Das S; Ehdaie A; Minnier J; Narayan S; Niebauer M; Raitt M; Tompkins C; Varma N; Chugh S; Tereshchenko LG
    J Interv Card Electrophysiol; 2018 Jun; 52(1):77-89. PubMed ID: 29541969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Prognostic Significance of Ventricular Repolarization Dispersion in Patients with Cardiac Sarcoidosis.
    Kobayashi Y; Nagai T; Takenaka S; Kato Y; Komoriyama H; Nagano N; Kamiya K; Konishi T; Sato T; Omote K; Tsujinaga S; Iwano H; Kusano K; Yasuda S; Ogawa H; Ishibashi-Ueda H; Anzai T
    Am J Cardiol; 2021 Aug; 152():125-131. PubMed ID: 34127248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of ECG Measures of Cardiac Repolarization in Relation to Arrhythmic Events in an Implantable Cardioverter Defibrillator Population.
    Shi B; Harding S; Larsen P
    Ann Noninvasive Electrocardiol; 2017 Mar; 22(2):. PubMed ID: 27292910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. J Waves Are Associated With the Increased Occurrence of Life-Threatening Ventricular Tachyarrhythmia in Patients With Nonischemic Cardiomyopathy.
    Naruse Y; Nogami A; Shinoda Y; Hanaki Y; Shirai Y; Kowase S; Kurosaki K; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1448-1453. PubMed ID: 27593399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy.
    Caliskan K; Szili-Torok T; Theuns DA; Kardos A; Geleijnse ML; Balk AH; van Domburg RT; Jordaens L; Simoons ML
    J Cardiovasc Electrophysiol; 2011 Aug; 22(8):898-904. PubMed ID: 21332865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
    Rowin EJ; Burrows A; Madias C; Estes NAM; Link MS; Maron MS; Maron BJ
    Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008123. PubMed ID: 32897759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.
    Gold MR; Ip JH; Costantini O; Poole JE; McNulty S; Mark DB; Lee KL; Bardy GH
    Circulation; 2008 Nov; 118(20):2022-8. PubMed ID: 18955671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.